Hubert Chen
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Hubert Chen is Chief Medical Officer at Attovia Therapeutics, Inc. since 2024.
Former positions include Medical Director at Genentech, Inc. and Senior Vice President-Clinical Development at Krystal Biotech, Inc. Education includes graduate studies at Harvard University and a doctorate from Stanford University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.08.2026 | 2.960 ( 0,01 % ) | 0 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 01.03.2024 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen